Full Text View
Tabular View
No Study Results Posted
Related Studies
Lapatinib and Cetuximab in Patients With Solid Tumors (TYKERB-ITUX 1)
This study is ongoing, but not recruiting participants.
Study NCT01184482   Information provided by Georgetown University

First Received on August 17, 2010.   Last Updated on February 11, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Colorectal Cancer
Lung Cancer
Head and Neck Cancer
Additional conditions recognized in this trial
Colorectal Neoplasms
Head and Neck Neoplasms
Lung Neoplasms
More general conditions related to this trial
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Lung Diseases
Neoplasms
Neoplasms by Site
Rectal Diseases
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Thoracic Neoplasms
Interventions listed in this trial
cetuximab and lapatinib
Additional drug interventions recognized in this trial
Cetuximab
Lapatinib
More general drug interventions related to this trial
Antineoplastic Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protein Kinase Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Georgetown University
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services